|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ang TL and Fock KM: Clinical epidemiology
of gastric cancer. Singapore Med J. 55:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park JY, von Karsa L and Herrero R:
Prevention strategies for gastric cancer: A global perspective.
Clin Endosc. 47:478–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klener P Jr, Andera L, Klener P, Necas E
and Zivny J: Cell death signalling pathways in the pathogenesis and
therapy of haematologic malignancies: Overview of therapeutic
approaches. Folia Biol (Praha). 52:119–136. 2006.PubMed/NCBI
|
|
6
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bianco R, Melisi D, Ciardiello F and
Tortora G: Key cancer cell signal transduction pathways as
therapeutic targets. Eur J Cancer. 42:290–294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ullmannova V and Haskovec C: Gene
expression during camptothecin-induced apoptosis in human myeloid
leukemia cell line ML-2. Neoplasma. 51:175–180. 2004.PubMed/NCBI
|
|
9
|
Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing
Q, Li J, Pang L, Chen K, Qiu F, et al: Matrine induced gastric
cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules
of Bcl-2 family. Toxicology. 229:245–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu
XX, Wu WY, Kang HF and Guan HT: Matrine induces apoptosis in
gastric carcinoma cells via alteration of Fas/FasL and activation
of caspase-3. J Ethnopharmacol. 123:91–96. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Q, Xiao Y, Liu T, Yuan H and Li C:
Demethylzeylasteral ameliorates inflammation in a rat model of
unilateral ureteral obstruction through inhibiting activation of
the NF-κB pathway. Mol Med Rep. 16:373–379. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Q, Yang C, Wang Q, Zeng H and Qin W:
Demethylzeylasteral (T-96) treatment ameliorates mice lupus
nephritis accompanied by inhibiting activation of NF-κB pathway.
PLoS One. 10:e1337242015.
|
|
13
|
Zhao JW, Wang GH, Chen M, Cheng LH and Ji
XQ: Demethylzeylasteral exhibits strong inhibition towards
UDP-glucuronosyltransferase (UGT) 1A6 and 2B7. Molecules.
17:9469–9475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai JP, Shi YL, Fang X and Shi QX: Effects
of demethylzeylasteral and celastrol on spermatogenic cell
Ca2+ channels and progesterone-induced sperm acrosome
reaction. Eur J Pharmacol. 464:9–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Ji Y, Fan J, Li F, Li Y, Wu M, Cheng
H and Xu C: Demethylzeylasteral (T-96) inhibits triple-negative
breast cancer invasion by blocking the canonical and non-canonical
TGF-β signaling pathways. Naunyn Schmiedebergs Arch Pharmacol.
392:593–603. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang K, Fu G, Pan G, Li C, Shen L, Hu R,
Zhu S, Chen Y and Cui H: Demethylzeylasteral inhibits glioma growth
by regulating the miR-30e-5p/MYBL2 axis. Cell Death Dis.
9:10352018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, He J, Li J, Peng X, Wang X, Dong
Z, Zhao E, Liu Y, Wu Z and Cui H: Demethylzeylasteral inhibits cell
proliferation and induces apoptosis through suppressing MCL1 in
melanoma cells. Cell Death Dis. 8:e31332017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, An R, Umanah GK, Park H, Nambiar
K, Eacker SM, Kim B, Bao L, Harraz MM, Chang C, et al: A nuclease
that mediates cell death induced by DNA damage and poly(ADP-ribose)
polymerase-1. Science. 354:aad68722016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HJ, Lee HJ, Lee EO, Ko SG, Bae HS, Kim
CH, Ahn KS, Lu J and Kim SH: Mitochondria-cytochrome C-caspase-9
cascade mediates isorhamnetin-induced apoptosis. Cancer Lett.
270:342–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao C, Yuan X, Jiang Z, Gan D, Ding L, Sun
Y, Zhou J, Xu L, Liu Y and Wang G: Regulation of AKT
phosphorylation by GSK3β and PTEN to control chemoresistance in
breast cancer. Breast Cancer Res Treat. 176:291–301. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sammons RM, Perry NA, Li Y, Cho EJ,
Piserchio A, Zamora-Olivares DP, Ghose R, Kaoud TS, Debevec G,
Bartholomeusz C, et al: A novel class of common docking domain
inhibitors that prevent ERK2 activation and substrate
phosphorylation. ACS Chem Biol. 14:1183–1194. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chambard JC, Lefloch R, Pouyssegur J and
Lenormand P: ERK implication in cell cycle regulation. Biochim
Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu F, Yang X, Geng M and Huang M:
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer
therapy. Acta Pharm Sin B. 8:552–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
den Hoed CM and Kuipers EJ: Gastric
cancer: How can we reduce the incidence of this disease? Curr
Gastroenterol Rep. 18:342016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heo SK, Yun HJ, Park WH and Park SD:
Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell
proliferation via caspase- and mitochondrial-dependent apoptosis. J
Cell Biochem. 105:70–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guerra F, Arbini AA and Moro L:
Mitochondria and cancer chemoresistance. Biochim Biophys Acta
Bioenerg. 1858:686–699. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akl H, Vervloessem T, Kiviluoto S,
Bittremieux M, Parys JB, De Smedt H and Bultynck G: A dual role for
the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus
endoplasmic reticulum. Biochim Biophys Acta. 1843:2240–2252. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Birkinshaw RW and Czabotar PE: The BCL-2
family of proteins and mitochondrial outer membrane
permeabilisation. Semin Cell Dev Biol. 72:152–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stennicke HR and Salvesen GS:
Caspases-controlling intracellular signals by protease zymogen
activation. Biochim Biophys Acta. 1477:299–306. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hill MM, Adrain C and Martin SJ: Portrait
of a killer: The mitochondrial apoptosome emerges from the shadows.
Mol Interv. 3:19–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhola PD and Letai A: Mitochondria-Judges
and executioners of cell death sentences. Mol Cell. 61:695–704.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Revathidevi S and Munirajan AK: Akt in
cancer: Mediator and more. Semin Cancer Biol. 59:80–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Staal PS: Molecular cloning of the akt
oncogene and its human homologues AKT1 and AKT2: Amplification of
AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci
USA. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roviello G, Ravelli A, Fiaschi AI,
Cappelletti MR, Gobbi A, Senti C, Zanotti L, Polom K, Reynolds AR,
Fox SB and Generali D: Apatinib for the treatment of gastric
cancer. Expert Rev Gastroenterol Hepatol. 10:887–892.
2016.PubMed/NCBI
|
|
36
|
Wu J, Yu J, Wang J, Zhang C, Shang K, Yao
X and Cao B: Astragalus polysaccharide enhanced antitumor effects
of Apatinib in gastric cancer AGS cells by inhibiting AKT
signalling pathway. Biomed Pharmacother. 100:176–183. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Geng W and Zhang HY: Research on the
mechanism of HP mediated PI3K/AKT/GSK3β pathways in gastric cancer.
Eur Rev Med Pharmacol Sci. 21 (3 Suppl):S33–S37. 2017.
|
|
38
|
Nakanishi K, Sakamoto M, Yamasaki S, Todo
S and Hirohashi S: Akt phosphorylation is a risk factor for early
disease recurrence and poor prognosis in hepatocellular carcinoma.
Cancer. 103:307–312. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Namba T, Kodama R, Moritomo S, Hoshino T
and Mizushima T: Zidovudine, an anti-viral drug, resensitizes
gemcitabine-resistant pancreatic cancer cells to gemcitabine by
inhibition of the Akt-GSK3β-Snail pathway. Cell Death Dis.
6:e17952015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao ZQ, Wang XX, Lu L, Xu JW, Li XB, Zhang
GR, Ma ZJ, Shi AC, Wang Y and Song YJ: β-sitosterol and gemcitabine
exhibit synergistic anti-pancreatic cancer activity by modulating
apoptosis and inhibiting epithelial-mesenchymal transition by
deactivating Akt/GSK-3β signaling. Front Pharmacol. 9:15252019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Qin X, Li P, Zhang H, Lin T, Miao Z
and Ma S: Isobavachalcone isolated from Psoralea corylifolia
inhibits cell proliferation and induces apoptosis via inhibiting
the AKT/GSK-3β/β-catenin pathway in colorectal cancer cells. Drug
Des Devel Ther. 13:1449–1460. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu W, Zhao Z, Wang Y, Li W, Su Q, Jia Q,
Zhang J, Zhang X, Shen J and Yin J: Dioscin inhibits stem-cell-like
properties and tumor growth of osteosarcoma through
Akt/GSK3/β-catenin signaling pathway. Cell Death Dis. 9:3432018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: A family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kohno M and Pouyssegur J: Pharmacological
inhibitors of the ERK signaling pathway: Application as anticancer
drugs. Prog Cell Cycle Res. 5:219–224. 2003.PubMed/NCBI
|
|
46
|
Wang H, Luo YH, Shen GN, Piao XJ, Xu WT,
Zhang Y, Wang JR, Feng YC, Li JQ, Zhang Y, et al: Two novel
1,4-naphthoquinone derivatives induce human gastric cancer cell
apoptosis and cell cycle arrest by regulating reactive oxygen
species-mediated MAPK/Akt/STAT3 signaling pathways. Mol Med Rep.
20:2571–2582. 2019.PubMed/NCBI
|
|
47
|
Chang HJ, Kim MH, Baek MK, Park JS, Chung
IJ, Shin BA, Ahn BW and Jung YD: Triptolide inhibits tumor
promoter-induced uPAR expression via blocking NF-kappaB signaling
in human gastric AGS cells. Anticancer Res. 27:3411–3417.
2007.PubMed/NCBI
|
|
48
|
Yanchun M, Yi W, Lu W, Yu Q, Jian Y,
Pengzhou K, Ting Y, Hongyi L, Fang W, Xiaolong C, et al: Triptolide
prevents proliferation and migration of esophageal squamous cell
cancer via MAPK/ERK signaling pathway. Eur J Pharmacol. 851:43–51.
2019. View Article : Google Scholar : PubMed/NCBI
|
